| Literature DB >> 26899439 |
Timethia Bonner1, Margaret Foster2, Erica Spears-Lanoix3.
Abstract
INTRODUCTION: The purpose of this systematic literature review is to review published studies on foot care knowledge and foot care practice interventions as part of diabetic foot care self-management interventions.Entities:
Keywords: diabetes; diabetic foot disease; foot care; foot care knowledge; self-care management
Year: 2016 PMID: 26899439 PMCID: PMC4761684 DOI: 10.3402/dfa.v7.29758
Source DB: PubMed Journal: Diabet Foot Ankle ISSN: 2000-625X
The strength of recommendations classification scheme
| IA | Evidence for meta-analysis of randomized, controlled trials |
| IB | Evidence from at least one randomized, controlled trial |
| IIA | Evidence from at least one controlled study without randomization |
| IIB | Evidence from at least one other type of quasi-experimental study (nonrandomized) |
| III | Evidence from non-experimental descriptive studies, such as comparative studies, correlation studies, and case-controlled studies |
| IV | Evidence from expert committee reports or opinions or clinical experience of respected authorities |
Adapted from Shekelle et al. (15).
Strength of reporting observational studies in epidemiology
| Item | Recommendation | |
|---|---|---|
| 1 | (1) Indicate the study's design with a commonly used term in the title and abstract. | |
| Background/rationale | 2 | Explain the scientific background and rationale for the investigation being reported. |
| Objectives | 3 | State specific objectives, including any prespecified hypotheses. |
| Study design | 4 | Present key elements of study design early in the paper. |
| Setting | 5 | Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data collection. |
| Participants | 6 | (1) Cohort study – give the eligibility criteria and the sources and methods of selection of participants Describe methods of follow-up. |
| Variables | 7 | Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers. Give diagnostic criteria, if applicable. |
| Data sources/measurement | 8 | For each variable of interest, give sources of data and details of methods of assessment (measurement). Describe comparability of assessment methods if there is more than one group. |
| Bias | 9 | Describe any efforts to address potential sources of bias |
| Study size | 10 | Explain how the study size was arrived at |
| Quantitative variables | 11 | Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen and why. |
| Statistical/methods | 12 | (1) Describe all statistical methods, including those used to control for confounding. |
| Participants | 13 | (1) Report number of individuals at each stage of study – e.g. number potentially eligible, examined for eligibility, confirmed eligible, included in the study, completing follow-up, and analyzed. |
| Descriptive data | 14 | (1) Give characteristics of study participants (e.g. demographic, clinical, social) and information on exposures and potential confounders. |
| Outcome data | 15 | Cohort study – report numbers of outcome events or summary measures over time. |
| Main results | 16 | (1) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision (e.g. 95% confidence interval). Make clear which confounders were adjusted for and why they were included. |
| Other analyses | 17 | Report other analyses done – e.g. analyses of subgroups and interactions, and sensitivity analyses. |
| Key results | 18 | Summarize key results with reference to study objectives. |
| Limitations | 19 | Discuss limitations of the study, taking into account sources of potential bias or imprecision. |
| Interpretation | 20 | Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results from similar studies, and other relevant evidence. |
| 21 | Discuss the generalizability (external validity) of the study results. |
Adapted from Vandenbroucke et al. (16).
An explanation and elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely available on the following websites: PLoS Medicine at www.plosmedicine.org/; Annals of Internal Medicine at www.annals.org/; and Epidemiology at www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.
Fig. 1Systematic review flow diagram on diabetes-related foot care knowledge and foot care skills interventions in US studies.